Skip to main content
SpringerLink
Log in

Contrast-induced nephropathy—time for Western medicine and Chinese medicine to team up

  • Feature Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lewington A, MacTier R, Hoefield R, Sutton A, Smith D, Downes M. Prevention of contrast induced acute kidney injury (CI-AKI) in adult patients. On behalf of the Renal Association, British Cardiovascular Intervention Society and The Royal College of Radiologists, 2013. Available at:http://www.renal.org/docs/default-source/guidelines-resources/ joint-guidelines/Prevention_of_Contrast_Induced_Acute_Kidney_Injury_CI-AKI_In_Adult_Patients.pdf.

    Google Scholar 

  2. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int Suppl 2012;2:69–88.

  3. Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989;36:730–740.

    Article  CAS  PubMed  Google Scholar 

  4. Gong X, Duan Y, Zheng J, Wang Y, Wang G, Norgren S, et al. Nephroprotective effects of N-acetylcysteine amide against contrast-induced nephropathy through upregulating thioredoxin-1, inhibiting ASK1/p38MAPK pathway, and suppressing oxidative stress and apoptosis in rats. Oxid Med Cell Longev 2016;2016:8715185.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Efferth T, Li PC, Konkimalla VB, Kaina B. From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 2007;13:353–361.

    Article  CAS  PubMed  Google Scholar 

  6. Zhao K, Li Y, Zhang H. Role of Dongchongxiacao (Cordyceps) in prevention of contrast-induced nephropathy in patients with stable angina pectoris. J Tradit Chin Med 2013;33:283–286.

    Article  PubMed  Google Scholar 

  7. Zhao K, Lin Y, Li Y, Gao S. Efficay of short-term cordyceps sinensis for prevention of contrast-induced nephropathy in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention. Int J Clin Exp Med 2014;7:5758–5764.

    PubMed  PubMed Central  Google Scholar 

  8. Yamaguchi Y, Kagota S, Nakamura K, Shinozuka K, Kunitomo M. Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis. Phytother Res 2000;14:647–649.

    Article  CAS  PubMed  Google Scholar 

  9. Huang J, Yuan M, Ma J, Liu R, Dong Z, Zhao G, et al. Protective effects of salvianolate on contrast-induced nephropathy after primary percutaneous coronary intervention: a prospective multicenter randomized controlled trial. Cardiology 2017;138:169–178.

    Article  CAS  PubMed  Google Scholar 

  10. Ozkan G, Ulusoy S, Orem A, Ersoz S, Alkanat M, Yucesan FB, et al. Protective effect of the grape seed proanthocyanidin extract in a rat model of contrast-induced nephropathy. Kidney Blood Press Res 2012;35:445–453.

    Article  CAS  PubMed  Google Scholar 

  11. Gong X, Wang Q, Tang X, Wang Y, Fu D, Lu H, et al. Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways. Am J Nephrol 2013;37:199–207.

    Article  CAS  PubMed  Google Scholar 

  12. Chu SC, Hu LH, Wang XL, Sun SQ, Zhang T, Sun Z, et al. Xuezhikang ameliorates contrast media-induced nephropathy in rats via suppression of oxidative stress, inflammatory responses and apoptosis. Renal Failure 2016;38:1717–1725.

    Article  CAS  PubMed  Google Scholar 

  13. Ulusoy S, Ozkan G, Mungan S, Yucesan FB. GSPE is superior to NAC in the prevention of contrast-induced nephropathy: might this superiority be related to caspase 1 and calpain 1? Life Sci 2014;103:101–110.

    Article  CAS  PubMed  Google Scholar 

  14. Kitano H. Computational systems biology. Nature 2002;420:206–210.

    Article  CAS  PubMed  Google Scholar 

  15. Jiang W. Therapeutic wisdom in tradtional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci 2005;26:558–563.

    Article  CAS  PubMed  Google Scholar 

  16. Konkimalla VB, Efferth T. Evidence-based Chinese medicine for cancer therapy. J Ethnopharmacol 2008;116:207–210.

    Article  PubMed  Google Scholar 

  17. Wang M, Xie T, Chang Z, Wang L, Xie X, Kou Y, et al. A new type of liquid silymarin proliposome containing bile salts: its preparation and improved hepatoprotective effects. PLoS ONE 2015;10(12): e0143625.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s and Women’s Health Theme, Karolinska University Hospital, SE-171 76, Stockholm, Sweden

    Svante Norgren & Xue-zhong Gong

  2. Department of Nephrology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China

    Svante Norgren & Xue-zhong Gong

Authors
  1. Svante Norgren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xue-zhong Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Svante Norgren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Norgren, S., Gong, Xz. Contrast-induced nephropathy—time for Western medicine and Chinese medicine to team up. Chin. J. Integr. Med. 24, 3–5 (2018). https://doi.org/10.1007/s11655-017-2905-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-017-2905-y

Search

Navigation